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Metabolic disordersAbstract Aim: The dietary contents have a very important role in the management of metabolic
syndrome along with type 2 diabetes mellitus (T2DM). Indian diet contains a large amount of
carbohydrates that set off unpredictable blood sugar ﬂuctuations and leads to increased risk of
diabetic complications. The aim of the present study was to identify the effect of mulberry tea in
the reduction of abnormally high postprandial blood glucose (PPG) levels in T2DM patients.
Methods: The study design was follow-up T2DM, 20 diabetic patients were given plain tea
(control) and 28 diabetic patients were given mulberry tea (test subject) to measure the effect of
mulberry tea on fasting blood glucose and PPG levels. Fasting blood glucose samples were collected
after a standard breakfast. The PPG levels were recorded after the consumption of 70 ml tea along
with 1 teaspoon of sugar after 90 min in all 48 patients.
Results: Fasting blood glucose levels in control and test group samples were found to be
178.55 ± 35.61 and 153.50 ± 48.10, respectively. After the consumption of plain tea and mulberry
tea, the PPG values were recorded as 287.20 ± 56.37 and 210.21 ± 58.73, respectively. A highly
signiﬁcant (p< 0.001) change in the PPG level was observed in response to mulberry tea in all the test
patients compared with control. Moreover, the effect size was also found to be very large (1.31).
Conclusion: Mulberry tea suppresses postprandial rise of blood glucose levels after 90 min of its con-
sumption.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Due to its high prevalence and potential deleterious effects,
type 2 diabetes mellitus (T2DM) continues to be a major
medical concern worldwide, especially in the developing coun-
tries (Zimmet, 2011). Despite remarkable growth in this ﬁeld of
research, the diabetes occurrence has been increasing very rap-
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gests that approx. 150 million people worldwide are affected
with diabetes and this number is expected to rise up to 300 mil-
lion by the year 2025 (Kumar et al., 2012). The diabetic para-
digm in India is also increasing rapidly and is expected to reach
approx. 57.2 million by the year 2025 (Kumar et al., 2012).
Some promising developments in the last decade in understand-
ing the pathophysiology of T2DM have fueled new approaches
toward its therapy and management. Recently, the usage of
some naturally derived phytochemicals for the treatment of
T2DM has been highlighted in the literature (Bulku et al.,
2010; Dembinska-Kiec et al., 2008; Leiherer et al., 2013).
T2DM is a metabolic disorder of the endocrine system, pri-
marily characterized by glycemic imbalance, which stimulates
several metabolic turbulence and ultimately results into oxida-
tive stress and chronic inﬂammation (American Diabetes
Association, 2010). Uncontrolled hyperglycemia could also
result in many chronic impediments such as micro-vascular
complications like neuropathy, stroke and peripheral vascular
disease (Cade, 2008). Medical complications of T2DM on the
central nervous system such as increased risk of Alzheimer’s dis-
ease and vascular dementia have also been reported (Banu et al.,
2013; Helzner et al., 2009; Jabir et al., 2014; Kamal et al., 2014).
Glycemic control is a primary concern in diabetic care as its
impairment leads to several complications andmess up the prog-
nosis among hospitalized diabetic patients (Kagansky et al.,
2003; Solı´s et al., 2012; Turchin et al., 2009). Overall glycemic
control could help and prevent the onset as well as delay in the
progression of long term complications of diabetes. It also
reduces morbidity and mortality of patients suffering from this
disease (Solı´s et al., 2012). The abnormal insulin secretion by
b-cells in response to a meal, impaired hepatic glucose produc-
tion and defective glucose uptake by peripheral insulin-sensitive
tissues (skeletal muscles) result into postprandial hyperglycemia
(PPG), which is a serious issue in the management of glycemic
patients. Moreover, control of the PPG level is critical in the
treatment of not only diabetic patients but also in individuals
with impaired glucose tolerance (Huang et al., 2012).
Recently, several treatment strategies for glycemic control
have been implemented, viz. change in life style, diet therapy,
use of synthetic and herbal agents (American Diabetes
Association, 2011; Kumar et al., 2012; Painter et al., 2013).
However, multiple medications are often needed to achieve
adequate glycemic control in majority of the patients
(American Diabetes Association, 2011; Painter et al., 2013;
Rodbard et al., 2009). Due to their limited adverse effects, her-
bal agents have gained attention for the treatment of various
diseases recently (Akilen et al., 2012; Kamboj et al., 2011;
Kumar et al., 2012; Prince et al., 1998; Tabrez et al., 2013).
The herbal agents as diabetic diet therapy could be quite effec-
tive in the management of carbohydrates in the normal diet.
One such agent, mulberry (Morus alba) plant leaf extracts have
been reported to possess several beneﬁcial effects against vari-
ous diseases. Glycemic control by mulberry leaf extracts due to
their therapeutic potential has also been reported in various
animal models (Chan et al., 2013; Jaruchotikamol and
Pannangpetch, 2013; Kim et al., 2011; Kwon et al., 2011;
Sharma et al., 2010). As far as our knowledge goes, there is
no literature available on the glucose lowering effect of
mulberry tea. This is the ﬁrst research article reporting the
effect of mulberry tea in reducing the PPG level in T2DM
patients.2. Materials and methods
In this study design, follow-up diabetic patients taking oral
anti-diabetic drugs were selected at Sri Jayadeva Institute of
Cardiovascular Sciences and Research, Bangalore, India. Fast-
ing blood glucose level was measured after routine standard
breakfast and after consumption of 70 ml of mulberry tea with
1 teaspoon of sugar. The PPG levels were measured in total 48
patients after prior consent and Institutional ethics committee
approval. Mulberry tea (Mulbericha green) was provided by
Karnataka State Sericulture Research and Development Insti-
tute, Bangalore, India.
2.1. Methods
The ﬁrst sample of fasting blood for glucose estimation was col-
lected in morning. All the patients were instructed to consume
routine standard breakfast (two idlis with chutney). Idli con-
tains fermented mixture of ground rice and beans. Each idli
contains approx. 1.67 g protein, 0.14 g fat, 9.12 g carbohy-
drates, 0.21 g minerals, 0.09 g ﬁbers and 44.5 Kcal energy.
Chutney is the coconut paste spiced up with chillies. The mul-
berry tea was prepared by the addition of one teaspoon of ‘Mul-
bericha green’ in one cup of hot water along with one teaspoon
of sugar and given to diabetic patients for drinking. Similarly,
the control group also consisted of diabetic patients and they
were given normal tea (70 ml). After 90 min, the second blood
sample was collected for the measurement of the PPG level.
Analyses were carried out on a Roche Hitachi 912 analyzer.
2.2. Statistical analysis
Descriptive statistical analyses were performed in this study.
Results on continuous measurements are presented as
Mean ± SD and results on categorical measurements are pre-
sented in number (%). Student’s t-test was performed to ﬁnd
out the signiﬁcance of study parameters on continuous scale
between two inter group analysis. Student’s t-test and
Chi-square test were also performed to identify the homogene-
ity of samples based on parameters on categorical scale
between two groups. Signiﬁcance was assessed at 5% level of
signiﬁcance.
2.3. Effect size
d ¼Mean1Mean2
Pooled SD
No eﬀect (N) d< 0.20
Small eﬀect (S) 0.20 < d< 0.50
Moderate eﬀect (M) 0.50 < d< 0.80
Large eﬀect (L) 0.80 < d< 1.20
Very large eﬀect (VL) d< 1.203. Results
The age of the patients involved in this study was in the range
of 30–70 years. The mean age of the control and test groups
34 S. Banu et al.was 53.80 ± 11.15 and 51.61 ± 8.59, respectively (Table 1).
Samples were age matched with P value of 0.445. The selected
subjects involved in this study were both males and females.
The control group consists of 50% males and 50% females,
and the test group consists of 57.1% males and 42.9% females.
Samples were gender matched with P value of 0.624 (Table 1).
The present study is a case control study for the estimation
of the effect of mulberry tea on the PPG level in 48 diabetic
patients divided into a test group (n= 28) and a control group
(n= 20). The subjects received a standardized breakfast
together with tea containing one teaspoon of sugar. The tea
was prepared from either mulberry leaf extract (test subjects)
or normal black tea (controls). Blood glucose level was mea-
sured at fasting state and after 90 min post-prandial state. Fast-
ing blood glucose levels in the control and test groups were
found to be 178.55 ± 35.61 and 153.50 ± 48.10, respectively.
After the consumption of plain tea and mulberry tea, the
PPG levels were found to be 287.20 ± 56.37 and 210.21 ±
58.73, respectively (Table 2). Our data clearly indicate a signif-
icant decline in the PPG level after 90 min in the test subjects
compared with that of the controls. The fasting and PPG levels
are presented in Table 2. The mean fasting blood sugar level in
the control and test groups was found to be 178.55 ± 35.61 and
153.50 ± 48.10, respectively. Moreover, a highly signiﬁcant
difference (p< 0.001) and very large size effect were also
observed in mean PPG level in test group subjects. The mean
PPG levels in the control and test groups were found to be
287.20 ± 56.37 and 210.21 ± 58.73, respectively.
4. Discussion
Post-prandial hyperglycemia represents a high risk factor for
the development of T2DM and cerebrovascular disease, possi-Table 1 Comparison of age distribution.
Control group Test group
No % No %
Age in years
30–40 3 15.0 3 10.7
41–50 4 20.0 11 39.3
51–60 8 40.0 9 32.1
61–70 5 25.0 5 17.9
Total 20 100.0 28 100.0
Mean ± SD 53.80 ± 11.15 51.61 ± 8.59
Samples were age matched with P= 0.445
Gender
Male 10 50.0 16 57.1
Female 10 50.0 12 42.9
Total 20 100.0 28 100.0
Samples were gender matched with P= 0.624
Table 2 Fasting blood glucose and PPG levels in the control and t
Variables Control group Te
Fasting blood glucose 178.55 ± 35.61 15
PPG 287.20 ± 56.37 21bly due to its causative factors such as impaired insulin secre-
tion, glucose production and/or defective glucose uptake by
peripheral insulin-sensitive tissues (Blaak et al., 2012; Derosa
and Mafﬁoli, 2012). Elevated PPG level also contributes signif-
icantly toward the promotion of oxidative stress, inﬂammation
and endothelial dysfunction; and leads to chronic diabetic
complications, particularly cardiovascular disease and micro-
vascular complications (Bell et al., 2008; Derosa and
Mafﬁoli, 2012; Shiraiwa et al., 2005). The underlying mecha-
nisms of reduced PPG level in T2DM prevention is not com-
pletely understood till now. However, its role in appetite
control or nutrient partitioning of markedly increased insulin
and glucose concentrations (Brand-Miller et al., 2002) which
assists in reducing total body weight has been reported in the
literature recently (Blaak et al., 2012).
Several agents have been suggested in scientiﬁc literatures
for the control of PPG level (Derosa and Mafﬁoli, 2012;
Ono et al., 2013; Tosh, 2013). Moreover, mammalian intestinal
a-glucosidase inhibitors are one of the potential agents for the
control of PPG levels (Huang et al., 2012). These agents could
reduce the absorption of disaccharides and polysaccharides,
which results in the decline of the PPG level (Huang et al.,
2012). In the present study, we report PPG lowering potential
of mulberry leaf extracts which could be beneﬁcial for treat-
ment, management and prognosis of diabetes. Furthermore,
as a glucose lowering agent, mulberry tea could also prevent
the progression and chronic complications to some extent.
Recently, herbal preparations have gained good attention
toward the treatment of various diseases all over the globe
(Devi et al., 2010). Recent developments in the ﬁeld of
phyto-pharmaceuticals have revealed the efﬁcacy and toxicity
associated with herbal agents and have become more popular
among public (Zaidi et al., 2014). In the present study, we used
leaf extracts of mulberry plant (M. alba) in a simple dietary
form i.e., tea. Tea is a very common drink used alone or along
with food. We believe that the mulberry plant derived extracts
could easily be complemented with the foods because of its
similar taste with normal tea.
Combined treatment approach is often considered to con-
trol glucose levels in diabetic patients (American Diabetes
Association, 2011; Painter et al., 2013). Several patients require
more than one treatment method to achieve adequate glycemic
control and usually 2–3 average medications are given to
patients with T2DM to reduce glucose levels. The primary
therapeutic approaches toward a better glycemic control
include proper diet management and changes in lifestyle. Syn-
thetic agents used to reduce carbohydrate absorption from the
intestine usually result in bloating gas and diarrhea (Chiasson
et al., 2002). However, these symptoms were not observed after
the consumption of mulberry tea. We, therefore, suggest the
consumption of mulberry tea as a preferred method of glyce-
mic control, which is also devoid of the side effects usually
associated with common anti-diabetic drugs.est groups.
st group Signiﬁcance Eﬀect size
3.50 ± 48.10 t= 1.972; 0.57 (M)
p= 0.055
0.21 ± 58.73 t= 4.492; 1.31 (VL)
p< 0.001
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their beneﬁcial effects against many diseases including cancer
and atherosclerosis (Chan et al., 2013; Deepa et al., 2012;
Jaruchotikamol and Pannangpetch, 2013; Park et al., 2012).
Mulberry extracts have been reported to exert chemo-preven-
tive potential on neuroblastoma cells, which could be helpful
for controlling the cell growth (Park et al. (2012). Puriﬁed mul-
berry leaf lectins have been reported to induce apoptosis and
cell cycle arrest in human breast and colon cancers (Deepa
et al. (2012). Cytoprotective activity of mulberry leaf extract
against oxidative stress induced cellular injury in rats has also
been reported (Jaruchotikamol and Pannangpetch (2013).
Moreover, the beneﬁcial effect of mulberry leaf extract in the
improvement of vascular endothelial functions has also been
reported, which prevents atherosclerosis by reducing the ather-
oma burden (Chan et al. (2013).
Blood glucose lowering potential of mulberry leaf extract has
also been reported in the scientiﬁc literature (Adisakwattana
et al., 2012; Naowaboot et al., 2012; Oku et al., 2006). A previous
study has reported the effect of mulberry tea on the inhibition of
a-glucosidase, which in turn prolongs carbohydrate absorption
process and helps to ﬂatten blood glucose levels (Ye et al.,
2002). Recently, one of the active components of mulberry leaf
extract (1-deoxynojirimycin) and its derivatives has been reported
to play an important role in delaying carbohydrate digestion by
inhibiting intestinal a-glucosidases (Adisakwattana et al., 2012;
Oku et al., 2006). Our study also supports the earlier reports of
glucose lowering potential of mulberry extracts and that its
consumption overcomes major side effects associated with
anti-diabetic drugs (Adisakwattana and Chanathong, 2011;
Adisakwattana et al., 2012; Park et al., 2009).
Having discussed our ﬁndings, we would like to mention
some of the limitations of our study. Although, we are suggest-
ing standard dietary intake of mulberry tea for the control of
PPG level, there could be intra-individual variations in exert-
ing the effect of mulberry tea toward various biological activ-
ities because of variations in the metabolic system of different
individuals. Our study also does not provide mechanistic
explanations on the active ingredients of mulberry extract,
which needs to be further investigated and explored.
5. Conclusion
With unabated rise of diabetes all across the world, the preven-
tion and management of this devastating disease are the need
of hour. Control of glycemic level especially after a meal is cru-
cial in both prevention as well as management of diabetes. The
results of the present study highlight the hypoglycemic effect of
mulberry tea after a routine standard breakfast. We believe
that delayed carbohydrate digestion after the consumption of
mulberry tea is due to the action of mulberry tea extract (1-
deoxynojirimycin) on the enzyme a-glucosidase. However,
the chemical complexity of mulberry tea and larger inter-
and intra-individual responses need to be considered and
explored in future studies.
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